Eisai’s “ URECE(R)” (Dotinurad) Approved in China for Gout Patients with Hyperuricemia
TOKYO, Dec 11, 2024 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today that it has received approval for “URECE®” (brand name in China: “优乐思®”, generic name: dotinurad)...